Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100443456C details a novel Lewis acid-catalyzed carbonylation route for 3,4-dimethylbenzaldehyde, offering superior purity and supply chain stability for fine chemical manufacturing.
Patent CN114213286B reveals a mild, metal-free route for urea derivatives using sodium carbonate and SO2F2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Reppe synthesis route for strawberry acid using Rh-catalysis. High yield, green chemistry, cost-effective manufacturing for flavor industry.
Novel carbonylation route for 4,4-dimethylisoxazol-3-one. High purity, green process for clomazone production. Cost-effective supply chain solution.
Patent CN1720217A details stable Pd-catalyzed route for lactate precursors. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN112142617A details a novel oxidative carbonylation method for synthesizing alpha,beta-unsaturated alkynamides with high selectivity and recyclable catalysts.
Patent CN107629051B reveals a novel three-step carbonylation route for evodiamine, offering streamlined production and cost advantages for pharmaceutical intermediates.
Discover how reductive aminocarbonylation with molybdenum carbonyl reduces raw material costs by 30-40% for (hetero)chroman amide synthesis. Scale-ready for API manufacturing.
Discover how reductive aminocarbonylation with molybdenum carbonyl dual role enables scalable chroman amide synthesis for pharmaceutical intermediates with 99%+ purity and broad functional group tolerance.
Solve amide synthesis challenges with nitroarene-based reductive aminocarbonylation. Reduce costs, expand functional group tolerance, and ensure supply chain stability for pharmaceutical intermediates.
Discover how nitroarene-based reductive aminocarbonylation enables scalable, high-yield chroman amide production for pharmaceutical intermediates with 99%+ purity and reduced supply chain risks.